The present disclosure relates to a method for assessing if a patient is affected with a lung cancer. The method includes analyzing the presence and amount of .beta.-citronellol contained in the urine excreted from the patient and determining if the presence and amount of .beta.-citronellol is indicative of lung cancer.

Panasonic Corporation

Method for determining whether or not a mammal is affected with a lung cancer

The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract of Litsea cubeba useful for the treatment of lung cancer. The present invention also relates to the activity of compounds C2 or C3 or C4 either alone or in combination in killing of A549 lung cancer cells.

Bhuyan; Mantu

Bhattacharyya; Pranab Ram

Baruah; Pranab Kumar

Barua; Nabin Chandra

Rao; Paruchuri G.

Bhattacharya; Sushmita

Kundu; Rakesh

Chatterjee; Priyajit

Seal; Soma

Mukherjee; Sandeep

Dasgupta; Suman

Moitra; Sudipta

Bhattacharya; Shelley

Bhattacharya; Samir

Council of Scientific &amp; Industrial Research

Synergistic pharmaceutical composition useful for the treatment of lung cancer

citronellol

سرطان

neoplasms

citronellol/سرطان

Method for determining whether or not a mammal is affected with a lung cancer

Synergistic pharmaceutical composition useful for the treatment of lung cancer

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم